Challenges in small-molecule target identification: a commentary on “BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models”

Benzer Materyaller

• BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models
  Yazar:: Vervloessem, Tamara, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth
  Yazar:: Deng, Jiusheng, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Small Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy
  Yazar:: Han, Bingshe, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• BH3 Response Profiles From Neuroblastoma Mitochondria Predict Activity of Small Molecule Bcl-2 Family Antagonists
  Yazar:: Goldsmith, Kelly C., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Small-molecule Bcl-2 antagonists as targeted therapy in oncology
  Yazar:: Warr, M.R., ve diğerleri
  Baskı/Yayın Bilgisi: (2008)